Compare TLPH & RMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLPH | RMCO |
|---|---|---|
| Founded | 2005 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Multi-Sector Companies |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.3M | 35.3M |
| IPO Year | 2010 | N/A |
| Metric | TLPH | RMCO |
|---|---|---|
| Price | $0.81 | $2.30 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 138.9K | 33.6K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 0.35% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,151,000.00 | N/A |
| Revenue This Year | N/A | $209.10 |
| Revenue Next Year | N/A | $133.33 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.38 | $1.03 |
| 52 Week High | $1.57 | $5.00 |
| Indicator | TLPH | RMCO |
|---|---|---|
| Relative Strength Index (RSI) | 45.75 | 42.36 |
| Support Level | $0.73 | $1.94 |
| Resistance Level | $0.87 | $2.48 |
| Average True Range (ATR) | 0.06 | 0.32 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 20.88 | 43.45 |
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Royalty Management Holding Corp is formed to invest or purchase assets that have near and medium-term income potential to provide RMC with accretive cash flow from which it can reinvest in new assets or expand cash flow from those existing assets. These assets typically are natural resources assets (including real estate and mining permits), patents, intellectual property, and emerging technologies.